Regeneron Pharmaceuticals shares owned by Checchi Capital Advisers
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Checchi Capital Advisers
from 13F filings
Historical chart of Checchi Capital Advisers investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Checchi Capital Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Checchi Capital Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $728k | 692 | 1051.24 |
| 2024-06-30 | $728k | 693 | 1051.03 |
| 2024-03-31 | $664k | 690 | 962.49 |
| 2023-12-31 | $586k | 667 | 878.29 |
| 2023-09-30 | $511k | 621 | 822.96 |
| 2023-06-30 | $472k | 657 | 718.54 |
| 2023-03-31 | $533k | 649 | 821.67 |
| 2022-12-31 | $455k | 630 | 721.49 |
| 2022-09-30 | $502k | 729 | 688.61 |
| 2022-06-30 | $417k | 717 | 581.59 |
| 2022-03-31 | $418k | 599 | 697.83 |
| 2021-12-31 | $335k | 530 | 632.08 |
| 2021-09-30 | $318k | 526 | 604.56 |
| 2021-06-30 | $281k | 503 | 558.65 |
| 2021-03-31 | $278k | 588 | 472.79 |
| 2020-12-31 | $320k | 662 | 483.38 |
| 2020-09-30 | $398k | 711 | 559.78 |
| 2020-06-30 | $440k | 706 | 623.23 |
| 2020-03-31 | $306k | 627 | 488.04 |
| 2019-12-31 | $245k | 652 | 375.77 |
| 2019-03-31 | $200k | 487 | 410.68 |
| 2018-09-30 | $278k | 689 | 403.48 |
| 2018-06-30 | $230k | 667 | 344.83 |
| 2018-03-31 | $217k | 629 | 344.99 |
| 2017-12-31 | $241k | 641 | 375.98 |
| 2017-09-30 | $241k | 540 | 446.30 |
| 2017-06-30 | $276k | 562 | 491.10 |
| 2017-03-31 | $243k | 626 | 388.18 |
| 2016-12-31 | $219k | 597 | 366.83 |
| 2016-09-30 | $257k | 639 | 402.19 |
| 2016-06-30 | $205k | 586 | 349.83 |
| 2016-03-31 | $219k | 607 | 360.79 |
| 2015-12-31 | $395k | 727 | 543.33 |
| 2015-09-30 | $248k | 534 | 464.42 |
| 2015-06-30 | $268k | 525 | 510.48 |
| 2015-03-31 | $249k | 551 | 451.91 |
| 2014-12-31 | $211k | 515 | 409.71 |